Saturday, October 31, 2026

Nikola Stock Went Up By Over 11% At Session Start On Wednesday

Nikola Stock Went Up By Over 11% At Session Start On Wednesday

Nikola Corporation (NASDAQ:NKLA), an Arizona-based technology innovator, saw an extraordinary jump of 11.27% at 10:10 EST on Wednesday following two days of losses. Meanwhile, NASDAQ experienced mild growth of 0.61% - continuing its upward trajectory after consecutive days of gains.

Nikola's Market Performance

Nikola, which provides energy and transportation solutions through its Truck and Energy business units, closed last session 77.37% below their 52-week high price point. However, recent gains indicate investor optimism.

Company's Challenges

A corporation specializing in commercializing battery electric vehicles (BEV) and hydrogen fuel cell electric vehicles (FCEV) for trucking has had an exciting but trying year as the stock market fluctuated among widespread uncertainty, forcing potential investors or stockholders to monitor such fluctuations carefully.

Financial Health

Nikola has earned a trailing twelve-month earnings per share (EPS) of 1.4, while its return on equity - which measures profitability related to shareholders' equity - stands at an alarming negative 137.05% for this same period.

Potential Risks

Nikola is in financial difficulty with more liabilities than assets, yet investors appear enthusiastic about potential growth prospects. Potential stockholders should conduct careful research and risk evaluation prior to investing.

Market Dynamics

Nikola's financial health as evidenced by its negative return on equity is cause for alarm, while their unexpectedly strong share prices suggest new market dynamics perhaps driven by their innovative presence in renewable energy sector.

More news about Nikola (NKLA).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com